IMRIC and the Manitoba government team up to fight Fetal Alcohol Spectrum Disorder

Share this
Blog: 
IMRIC and You
By: 

Sidney Slivko

Sidney Slivko Photo

I am a writer and teacher who has always had an interest in science. Well, science fiction, at any rate. Not the bug-eyed monster type, but the kind of sci-fi that speculated on what the world would look like 10, 20 or 100 years from now. Innovation and new ideas excite me, as do the changes they  bring to our lives, whether it's a new toy I've got to get, a new application I want to add to my laptop, a new puzzle to solve or a new food I haven't tasted yet.

Manitoba's Innovation, Energy and Mines Minister Dave Chomiak announced today that the Manitoba government is partnering with IMRIC – The Institute for Medical research Israel-Canada -- to address Fetal Alcohol Spectrum Disorder (FASD).

The new Canada-Israel FASD consortium brings together teams from the University of Manitoba and The Hebrew University of Jerusalem and will focus on the research conducted by IMRIC researcher Professor Abraham Fainsod on FASD and how it can be prevented.  "We are pleased to support efforts to bring researchers together from the Hebrew University of Jerusalem and the University of Manitoba to study FASD, said Chomiak, "and create long-term social, economic and health benefits for Manitobans." said Chomiak.

On a recent trip to Israel, John Clarkson, Deputy Minister for Innovation, Energy and Mines remarked: "We were here first in June on to learn about IMRIC and its projects.  That's when Professor Fainsod made his presentation.  We visited the labs and found them to be a first-rate facility. It's easy to understand why first rate research comes out of IMRIC,"

"This new collaboration and partnership is absolutely essential if we want to find solutions to the complicated health challenges facing our world in the 21st century," said Dr. Digvir S. Jayas,  vice-president of research and distinguished professor at the University of Manitoba.  "Our researchers, working alongside colleagues at Hebrew University in Israel, will help unlock the key to preventing FASD and translate those findings into better treatments for people around the world."

"Over the next 3 to 6 months we're looking forward to bringing some fairly solid definitions to what the next stages will be.  We will see significant results over the next 3 to 5 years," said Clarkson